Optimal management of acute toxicities of therapy.
Gootenberg
J E
JE
Department of Pediatrics, Georgetown University School of Medicine, Washington, DC.
Pizzo
P A
PA
D000380:Agranulocytosis / Q000139:chemically induced / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001424:Bacterial Infections / Q000188:drug therapy; D002648:Child; D003248:Constipation / Q000139:chemically induced / Q000628:therapy; D005335:Fever of Unknown Origin / Q000209:etiology / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007668:Kidney / Q000187:drug effects; D008659:Metabolic Diseases / Q000139:chemically induced / Q000628:therapy; D009325:Nausea / Q000139:chemically induced / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy; D009748:Nutrition Disorders / Q000628:therapy; D010146:Pain / Q000209:etiology; D059408:Pain Management; D001743:Urinary Bladder / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced / Q000628:therapy
D000970:Antineoplastic Agents